Eric T Wong, Steven Brem. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Angiogenesis Inhibitors/administration & dosageAntibodies, Monoclonal/administration & dosageAntibodies, Monoclonal, HumanizedAntineoplastic Agents, Alkylating/administration & dosageAntineoplastic Combined Chemotherapy Protocols/therapeutic useBevacizumabBrain Neoplasms/blood supplyBrain Neoplasms/therapyClinical Trials, Phase II as TopicDacarbazine/administration & dosageDacarbazine/analogs & derivativesGlioblastoma/blood supplyGlioblastoma/therapyHumansNeovascularization, Pathologic/drug therapyNeovascularization, Pathologic/radiotherapyTemozolomide
Substances: See more » Angiogenesis InhibitorsAntibodies, MonoclonalAntibodies, Monoclonal, HumanizedAntineoplastic Agents, AlkylatingBevacizumabDacarbazineTemozolomide
Year: 2010 PMID: 21135277 DOI: 10.1200/JCO.2010.32.5282
Source DB: PubMed Journal: J Clin Oncol ISSN: 0732-183X Impact factor: 44.544